SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-14-002457
Filing Date
2014-05-21
Accepted
2014-05-21 10:49:01
Documents
22
Period of Report
2014-05-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_052114.htm 8-K 24073
2 EXHIBIT 99.1 exh_991.htm EX-99.1 18835
3 exh991_01.jpg GRAPHIC 117491
4 exh991_02.jpg GRAPHIC 215575
5 exh991_03.jpg GRAPHIC 181851
6 exh991_04.jpg GRAPHIC 133127
7 exh991_05.jpg GRAPHIC 183050
8 exh991_06.jpg GRAPHIC 157343
9 exh991_07.jpg GRAPHIC 173527
10 exh991_08.jpg GRAPHIC 230196
11 exh991_09.jpg GRAPHIC 216099
12 exh991_10.jpg GRAPHIC 165741
13 exh991_11.jpg GRAPHIC 224480
14 exh991_12.jpg GRAPHIC 175086
15 exh991_13.jpg GRAPHIC 167208
16 exh991_14.jpg GRAPHIC 181319
17 exh991_15.jpg GRAPHIC 191657
18 exh991_16.jpg GRAPHIC 203567
19 exh991_17.jpg GRAPHIC 232161
20 exh991_18.jpg GRAPHIC 156425
21 exh991_19.jpg GRAPHIC 147221
22 exh991_20.jpg GRAPHIC 130667
  Complete submission text file 0001171843-14-002457.txt   4984275
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33560 | Film No.: 14859874
SIC: 2834 Pharmaceutical Preparations